Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer
/in International Publications, Ovarian Cancer /von 2002-04-01 / Minerva Ginecol 2002 Apr;54(2):133-44Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma
/in International Publications, Malignant Lymphoma /von 2002-04-01 / Haematologica 2002 Apr;87(4):400-7Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2002-04-01 / Blood 2002 Apr;99(7):2512-7IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution